The rapidly evolving IV2D field offers important opportunities to diagnostic imaging companies. While imaging continues to see important refinements, the development of new imaging systems is challenging. In contrast, substantial numbers of in-vivo biomarkers are being discovered, offering combined "hybrid" integrations with imaging.
Siemens is a global provider of medical diagnostic systems, incorporating primary tests and instrumentation, IT platforms and software solutions, for clinical data handling and processing. Siemens is also developing technologies in the field of integrated diagnostics.
Key reasons to purchase this research- What are the major imaging systems in diagnosis and how are they being applied to diagnosis in breast cancer and Alzheimer's disease?
- What are the business models of some of the major diagnostic companies as they establish new integrated diagnostic and healthcare capabilities?
- What levels of support and capability do healthcare providers seek from companies offering products and services in the fields of diagnostics?
- What strategies are the major diagnostic companies taking to reduce costs of the healthcare products and services?
- Why is it anticipated that the next decade will see substantial growth in the integrated diagnostics field?
To order this report:: The Future of In Vitro and In Vivo Diagnostic Integration
Check our Company Profile, SWOT and Re
Copyright©2010 PR Newswire.
All rights reserved